tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Astellas and Pfizer Unveil Breakthrough in Bladder Cancer Treatment
Company AnnouncementsAstellas and Pfizer Unveil Breakthrough in Bladder Cancer Treatment
2d ago
Astellas Pharma Revises FY2025 Financial Forecasts Upward
PremiumCompany Announcements
Astellas Pharma Revises FY2025 Financial Forecasts Upward
2M ago
Astellas Pharma (ALPMF) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Astellas Pharma (ALPMF) Q2 Earnings Cheat Sheet
2M ago
Astellas Pharma’s GLEAM Trial Falls Short of Primary Endpoint in Pancreatic Cancer Study
PremiumCompany Announcements
Astellas Pharma’s GLEAM Trial Falls Short of Primary Endpoint in Pancreatic Cancer Study
2M ago
Astellas Pharma’s IZERVAY Gains Conditional Approval in Japan for Geographic Atrophy
PremiumCompany Announcements
Astellas Pharma’s IZERVAY Gains Conditional Approval in Japan for Geographic Atrophy
3M ago
Astellas Pharma: Hold Rating Amid Growth Challenges and Product Limitations
PremiumRatingsAstellas Pharma: Hold Rating Amid Growth Challenges and Product Limitations
4M ago
Pfizer and Astellas Announce Breakthrough in Bladder Cancer Treatment
Premium
Company Announcements
Pfizer and Astellas Announce Breakthrough in Bladder Cancer Treatment
4M ago
Astellas Reports Strong Preliminary Sales for IZERVAY™ in Q1 FY2025
Premium
Company Announcements
Astellas Reports Strong Preliminary Sales for IZERVAY™ in Q1 FY2025
5M ago
Astellas Pharma Continues Performance-linked Stock Schemes for Executives
PremiumCompany Announcements
Astellas Pharma Continues Performance-linked Stock Schemes for Executives
7M ago
Astellas Pharma Continues Performance-linked Stock Compensation Scheme for 2025
PremiumCompany Announcements
Astellas Pharma Continues Performance-linked Stock Compensation Scheme for 2025
7M ago
Astellas Pharma Announces Changes to Board of Directors
PremiumCompany Announcements
Astellas Pharma Announces Changes to Board of Directors
8M ago
Astellas Pharma Reports Record Revenue and Growth
PremiumCompany Announcements
Astellas Pharma Reports Record Revenue and Growth
8M ago
Astellas Pharma Reports Higher Than Expected Financial Results
PremiumCompany AnnouncementsAstellas Pharma Reports Higher Than Expected Financial Results
8M ago
ALPMF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ALPMF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
8M ago
FDA Approves Extended Use of Astellas’ IZERVAY for Geographic Atrophy
Premium
Company Announcements
FDA Approves Extended Use of Astellas’ IZERVAY for Geographic Atrophy
10M ago
Astellas Pharma Reports Extraordinary Losses in Non-Consolidated Financial Results
PremiumCompany Announcements
Astellas Pharma Reports Extraordinary Losses in Non-Consolidated Financial Results
11M ago
Astellas Pharma’s Earnings Call: Mixed Outcomes and Strategic Shifts
PremiumCompany Announcements
Astellas Pharma’s Earnings Call: Mixed Outcomes and Strategic Shifts
11M ago
ALPMF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
ALPMF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
11M ago
Astellas Pharma Revises 2024 Financial Forecast Amid Core Business Growth and Impairment Losses
PremiumCompany Announcements
Astellas Pharma Revises 2024 Financial Forecast Amid Core Business Growth and Impairment Losses
11M ago
Astellas Pharma’s Resubmission for IZERVAY Accepted by FDA
PremiumCompany AnnouncementsAstellas Pharma’s Resubmission for IZERVAY Accepted by FDA
11M ago
Astellas Faces FDA Setback on IZERVAY Application
Premium
Company Announcements
Astellas Faces FDA Setback on IZERVAY Application
1y ago
Astellas Pharma Faces Currency Losses in FY2024
Premium
Company Announcements
Astellas Pharma Faces Currency Losses in FY2024
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >